Previous close | 86.81 |
Open | 87.09 |
Bid | 84.04 x 800 |
Ask | 88.12 x 1100 |
Day's range | 85.91 - 87.71 |
52-week range | 62.11 - 97.49 |
Volume | |
Avg. volume | 2,237,851 |
Market cap | 22.121B |
Beta (5Y monthly) | 1.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.60 (1.85%) |
Ex-dividend date | 21 Jun 2024 |
1y target est | N/A |
IFF, a global leader in food and beverage, home and personal care and health, will introduce its full suite of plant-based and cellulosic-derived solutions for dietary supplements and over-the-counter (OTC) drugs at Vitafoods Europe 2024. This is the first time IFF Pharma Solutions will showcase its full clean-label portfolio for oral dosage forms at Vitafoods Europe, May 14-16, Geneva, Switzerland, booth E90.
NEW YORK, May 01, 2024--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 10, 2024 to shareholders of record as of June 21, 2024.
IFF's Pharma Solutions division will highlight innovative solutions to help pharmaceutical manufacturers seeking science-backed excipients with effective strategies to support their nitrosamine risk mitigation plans at Excipient World 2024, May 13-15, Gaylord Palms Resort and Convention Center, Kissimmee, Florida at booth 214.